The novel -opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice

By Tsuji M.   Yamazaki M.   Takeda H.   Matsumiya T.   Nagase H.   Tseng L.F.   Narita M.   Suzuki T.  

European Journal of Pharmacology, Vol. 394, Iss. 1, 2000-04 ,pp. : 91-95

Elsevier

Access to resources Recommend Favorite

Pharmacological properties of TRK-820 on cloned -, - and -opioid receptors and nociceptin receptor

By Seki T.   Awamura S.   Kimura C.   Ide S.   Sakano K.   Minami M.   Nagase H.   Satoh M.  

European Journal of Pharmacology, Vol. 376, Iss. 1, 1999-07 ,pp. : 159-167

Elsevier

Access to resources Recommend Favorite

Blockade of -opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice

By Mizoguchi H.   Hung K.-c.   Leitermann R.   Narita M.   Nagase H.   Suzuki T.   Tseng L.F.  

European Journal of Pharmacology, Vol. 461, Iss. 1, 2003-02 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite

Pharmacological Properties of Novel Cyclic Pentapeptides with μ-opioid Receptor Agonist Activity

By  

Medicinal Chemistry, Vol. 10, Iss. 2, 2014-03 ,pp. : 154-161

Bentham Science Publishers

Access to resources Recommend Favorite

Phorbol ester blocks the increase of a high affinity GTPase activity induced by 2 -opioid receptor agonist in the mouse spinal cord

By Narita M.   Mizoguchi H.   Tseng L.F.  

European Journal of Pharmacology, Vol. 310, Iss. 2, 1996-08 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite